Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03786783
Brief Title: Dinutuximab, Sargramostim, and Combination Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma Undergoing Stem Cell Transplant

First Submitted : December 24, 2018
First Submitted that Met QC Criteria : December 24, 2018
First Posted : December 25, 2018 (Estimate)

Last Update Submitted that Met QC Criteria : September 9, 2019
Last Update Posted : September 10, 2019